Posts Tagged "pioglitazone"

FDA Studying Possible Link Between Pioglitazone and Bladder Cancer

Posted on Sep 20, 2010 in Uncategorized

Robert Lowes   September 19, 2010 — Preliminary epidemiological evidence suggests that the diabetic medication pioglitazone (Actos; Takeda Pharmaceutical) may be linked to a higher risk for bladder cancer, a possible relationship that warrants further study, the US Food and Drug Administration (FDA) said on September 17. As with other announcements about drugs under postmarket scrutiny, the agency noted that it has not concluded that pioglitazone increases the risk for bladder cancer and urged patients taking the medication to continue to do so unless told otherwise by their healthcare...

Read More